European Society of Cardiology Congress 2011
European Society of Cardiology Congress 2011 | ISO | 2.26 GB
Webcasts from August 29th Paris European Society of Cardiology Congress
New developments in the diagnosis of atrial fibrillation.
New antithrombotic therapies: revisiting stroke prevention in atrial fibrillation.
Rate and rhythm control in atrial fibrillation: redefining goals.
Will catheter ablation of atrial fibrillation withstand the test of randomised studies.
How to use aldosterone blockers.
Heart rate as a target.
Current indications for resynchronisation therapy.
Telemonitoring in clinical practice.
Peripheral artery disease.
Acute coronary syndrome and non ST-elevation.
Cardiovascular disease during pregnancy.
Impact on pharmacology of cardiovascular drugs.
In heart failure.
In acute coronary syndrome.
Management of the cyanotic patient.
ECOST: Safety of implantable cardioverter defibrillator follow-up using remote monitoring: a randomized controlled trial
Discussant - ECOST: Safety of implantable cardioverter defibrillator follow-up using remote monitoring: a randomized controlled trial
Discussant - EMPHASIS-HF. The effect of eplerenone versus placebo on cardiovascular mortality or heart failure hospitalization in subjects with NYHA class II chronic systolic heart failure: An analysis of the High-risk groups in the study population
RESET: One-year outcome of the Randomized Evaluation of Sirolimus-eluting versus Everolimus-eluting stent Trial
Discussant - RESET: One-year outcome of the Randomized Evaluation of Sirolimus-eluting versus Everolimus-eluting stent Trial
Comparison of three-year outcome after PCI and CABG stratified by the SYNTAX score in patients with triple vessel coronary artery disease: an observation from the CREDO-Kyoto PCI/CABG registry Cohort-2
Discussant - Comparison of three-year outcome after PCI and CABG stratified by the SYNTAX score in patients with triple vessel coronary artery disease: an observation from the CREDO-Kyoto PCI/CABG registry Cohort-2
A case of hypertrophic cardiomyopathy with left bundle branch block and severe heart failure.
What do the Guidelines say
Tailored antithrombotic therapy in non ST-elevation-acute coronary syndrome.
What do the Guidelines say
Stroke and bleeding risk assessment in a high risk atrial fibrillation patient who needs a coronary stent.
The 'truly low stroke risk' patient with atrial fibrillation: defining the population and what to do post-ablation.
Scope of the problem.
Cerebral artery disease.
Mesenteric and renal artery disease.
Lower extremity artery disease.
Is the optimisation of the atrioventricular and interventricular delays useful
How to manage cardiac resynchronisation therapy in atrial fibrillation patients
The use of cardiac resynchronisation therapy outside current guidelines.
Effectiveness in the RESPONSE trial.
Feasibility in the EUROACTION study.
Should we only focus on nurse-led programmes
Do we know how to do it
ASE/EAE recommendations about echo assessment of left ventricular mechanics.
EAE position paper on pocket size imaging devices.
EAE recommendations about the use of echo in Emergency Department.
When to intervene.
Rationale for surgery.
Rationale for stenting.
SMART-AV: The role of electrical delay (QLV) to predict left ventricular reverse remodeling with cardiac resynchronization therapy
Discussant - SMART-AV: The role of electrical delay (QLV) to predict left ventricular reverse remodeling with cardiac resynchronization therapy
PACE: Biventricular pacing superior to right ventricular pacing in bradycardia patients with preserved systolic function: two-year results of PACE trial
Discussant - PACE: Biventricular pacing superior to right ventricular pacing in bradycardia patients with preserved systolic function: two-year results of PACE trial
Discussant - IRIS: Why does the implantable cardioverter-defibrillator not improve mortality early after myocardial infarction - Insights from the Immediate Risk Stratification Improves Survival (IRIS) trial
SHIFT: Relationship between heart rate and health related quality of life. Results from SHIFT
Discussant - SHIFT: Relationship between heart rate and health related quality of life. Results from SHIFT
SHIFT: Selective heart rate reduction with Ivabradine improves left ventricular remodeling and function: insights from the SHIFT-Echocardiography sub-study
Discussant - SHIFT: Selective heart rate reduction with Ivabradine improves left ventricular remodeling and function: insights from the SHIFT-Echocardiography sub-study
Discussant - STICH: Influence of mitral valve repair on survival in the surgical treatment for Ischemic heart failure trial
'Old Therapies': how was myocardial infarction management in 1970
Future therapies for myocardial infarction in 2050: cells genetics and pharmacogenomics.
Future interventional therapies and new devices for myocardial infarction in 2050.
Difficult echocardiography in an adult patient previously unknown to have congenital heart disease.
Difficult echocardiography in an adult patient with repaired congenital heart disease.
Role of 2D and 3D echo in aortic stenosis- Tips and tricks.
Is there a role for computed tomography/myocardial magnetic resonnance imaging in aortic stenosis
Integration of coronary anatomy function perfusion and metabolism.
Myocardial characterisation using cardiovascular magnetic resonnance.
Optical coherence tomography in acute coronary syndrome.
Intravascular ultrasound to optimize percutaneous intervention results.
New therapy for atherosclerosis targeting folate receptor-beta expressing macrophages
Effector memory T cells are related to the atherosclerotic process in humans and murine models
Essential role of CD4 T cells in Angiotensin II-induced atherosclerosis and vulnerable atherosclerotic plaque development
MicroRNA expression in peripheral blood monocytes in different stages of atherosclerosis development in humans
Sodium channelopathies in the developing heart - a key to understanding adult arrhythmogenesis.
Linking Pitx2 insufficiency to atrial fibrillation.
Brugada syndrome: a developmental perspective.
Calcium channelopathies: current appraisal and future hopes.
Predicting survival in chronic heart failure: a risk score based on 47886 patients from 31 studies
Prognostic value of baseline NT-proBNP and its interactions with irbesartan treatment in patients with heart failure and preserved ejection fraction: Findings from the I-PRESERVE trial
Serial measurement of cardiac troponin T using a highly sensitive assay in patients with chronic heart failure. Results from two large randomized clinical trials
State of the Art - Probing prognosis in heart failure
A rare variant in MYH6 confers high risk of sick sinus syndrome
A dominant negative missense mutation in MOG1 induces trafficking defect of cardiac sodium channel and is associated with Brugada syndrome ECG pattern
State of the Art - Featured research on genetic aspects of cardiac arrhythmias
Diagnosis and risk stratification.
Antiplatelet and anticoagulation treatment.
Sympathetic nerve traffic insulin resistance and baroreflex control of circulation in patients with resistant hypertension.
Addition of spironolactone in patients with resistant arterial hypertension (ASPIRANT): a randomized double-blind placebo-controlled trial
Confirmation of sustainability of hemodynamic response to baroreflex activation therapy in patients with resistant hypertension
Effects of percutaneous renal denervation in patients with resistant hypertension on ambulatory blood pressure measurement and dipping
State of the Art - Can we cure resistant hypertension
Smoking and obesity/overweight: relations to all-cause mortality and major cardiovascular in a population-based cohort of men and women
Smokeless tobacco (snus) and mortality after myocardial infarction
Reduced incidence of ST-elevation myocardial infarction in the first two years after introduction of a public smoking ban in canton ticino switzerland
Smoking relapse and mortality after acute coronary syndromes
State of the Art - Tobacco use no smoke without fire.
Persistent smoking in high-risk patients - the reality in clinical practice and how to improve.
Strategies for smoking cessation - evidence from trials.
Right ventricular adaptation to pressure load in mice is improved after blockade of calcineurin activation
Baseline difference in transcriptional patterns between PAH patients and normal volunteers
Absence of influence of gender and BMPR2 mutation type on clinical phenotypes of pulmonary arterial hypertension
State of the Art - Pathobiological changes in pulmonary arterial hypertension
Multidetector computed tomography.
Invasive diagnostic procedures.
Transforming growth factor is linked to abnormal collagen turnover leading to impaired myocardial deformation in untreated hypertensives
Global two-dimensional strain as a novel parameter of myocardial fibrosis and the assessment of risk for major cardiac events in patients with hypertrophic cardiomyopathy
Association of imaging markers of myocardial fibrosis with metabolic and functional disturbances in early diabetic cardiomyopathy: a multi-modality study
Epicardial fat volume on non-contrast computed tomography is associated with high-risk coronary artery plaque features
Platelet reactivity on clopidogrel therapy and cardiovascular outcomes after percutaneous coronary intervention: a time-dependent pharmacodynamic analysis of the GRAVITAS trial
Impact of the cytochrome P450 2C19*3 polymorphism on platelet reactivity and adverse clinical events in patients with acute myocardial infarction
The Italian Elderly ACS study: Early aggressive versus initially conservative strategy in elderly patients with non-ST- elevation acute coronary syndrome: the Italian Elderly ACS randomised trial (ClinicalTrials.gov ID: NCT00510185)
Is clopidogrel discontinuation following acute coronary syndrome hospitalisation associated with a higher risk of death and myocardial infarction
The PACIFIC registry: one-year follow-up data of a 2-Year study in patients initially hospitalised with ACS
The European CRT survey: 1 year follow-up results
FRANCE II: French registry aortic national corevalve and Edwards registry II
Considerably lower risk of stent thrombosis and restenosis in "new generation" drug-eluting stents: a report from the nation wide complete Swedish Coronary Angiography and Angioplasty Registry (SCAAR)
Longterm clinical outcomes and duration of dual antiplatelet therapy after drug-eluting stent implantation: landmark analyses from CREDO-KYOTO Cohort-2 registry
Primary percutaneous coronary intervention as a national reperfusion strategy in patients with ST-elevation myocardial infarction: eleven years of experience from the western denmark heart registry.
Improved two-year outcomes of STEMI patients treated with drug-eluting compared with bare-metal stents. Experiences from the randomized BASKET-PROVE trial
State of the Art - Old challenges in interventional cardiology: new answers from very large multicenter studies